Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study

Annals of Indian Academy of Neurology

Volumn 17, Issue 1, 2014, Pages 19-24

  Vasudevan, D ^a   Naik, Manoj M ^b   Mukaddam, Qayum I ^b  

^a Brain Spine and Nerve Centre   (India)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Alpha lipoic acid (ALA); Diabetic neuropathy; Methylcobalamin; Pregabalin

Indexed keywords

MECOBALAMIN; PREGABALIN; THIOCTIC ACID;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ADULT; ADULT DISEASE; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL LABORATORY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FEMALE; FOLLOW UP; HUMAN; MALE; MONOTHERAPY; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NUMERIC RATING SCALE; OPEN STUDY; PAIN ASSESSMENT; PARALLEL DESIGN; PATIENT ASSESSMENT; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK ASSESSMENT; SCORING SYSTEM; SLEEP INTERFERENCE SCORE;

EID: 84898762551     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.128535     Document Type: Article

References (21)

1. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-8.
2. Harati Y. Diabetes and the nervous system. Endocrinol Metab Clin North Am 1996;25:325-59.
3. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. American Diabetes Association. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 2005;28:956-62.
4. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-4.
5. Pirart J. Diabetes mellitus and its degenerative complication: A prospective study of 4,400 patient observed between 1947 and 1973. Diabetes Care 1978;1:168-88.
6. Akaike A, Tamura Y, Sato Y, Yokota T. Protective effects of a vitamin B12 analogue, methylcobalamin, against glutamate cytotoxicity in cultured cortical neurons. Eur J Pharmacol 1993;241:1-6.
7. Ziegler D, Reljanovic M, Mehnert H, Gries FA. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: Current evidence from clinical trials. Exp Clin Endocrinol Diabetes 1999;107:421-30.
8. American Diabetic Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27 (suppl 1): S5-10.
9. Kimura J. Electrodiagnosis in diseases of nerve and muscle: Principles and Practice Philadelphia: FA Davis; 1989.
10. Boulton AJ, Malik RA. Diabetic neuropathy. Med Clin North Am 1998;82:909-29.
11. Ryle C, Donaghy M. Non-enzymatic glycation of peripheral nerve proteins in human diabetics. J Neurol Sci 1995;129:62-8.
12. Greene DA, Arezzo JC, Brown MB. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Neurology 1999;53:580-91.
13. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:1842-6.
14. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: The SYDNEY 2 trial. Diabetes Care 2006;29:2365-70.
15. Vallianou N, Evangelopoulos A, Koutalas P. Alpha-lipoic Acid and diabetic neuropathy. Rev Diabet Stud 2009;6:230-6.
16. Skalská S, Kucera P, Goldenberg Z, Stefek M, Kyselová Z, Jariabka P, et al. Neuropathy in a rat model of mild diabetes induced by multiple low doses of streptozotocin: Effects of the antioxidant stobadine in comparison with a high-dose alpha-lipoic acid treatment. Gen Physiol Biophys 2010;29:50-8.
17. Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy. The NATHAN 1 trial. Diabetes Care 2011;34:2054-60.
18. Jalaludin MA. Methylcobalamin treatment of Bell's Palsy. Methods Find Exp Clin Pharmacol 1995;17:539-44.
19. Kikuchi M, Kashii S, Honda Y, Tamura Y, Kaneda K, Akaike A. Protective effects of methylcobalamin, a vitamin B12 analogue, against glutamate-induced neurotoxicity in retinal cell culture. Invest Ophthalmol Vis Sci 1997;38:848-54.
20. Yamazaki K, Oda K, Endo C, Kikuchi T, Wakabayashi T. Methylcobalamin (methyl-B12) promotes regeneration of motor nerve terminals degenerating in anterior gracile muscle of gracile axonal dystrophy (GAD) mutant mouse. Neurosci Lett 1994;170:195-7.
21. Sun Y, Lai MS, Lu CJ. Effectiveness of vitamin B12 on diabetic neuropathy: Systematic review of clinical controlled trials. Acta Neurol Taiwan 2005;14:48-54.